• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硫醇蛋白酶抑制剂EST可抑制凝血酶诱导的血小板活化。

Thiolprotease inhibitor, EST, can inhibit thrombin-induced platelet activation.

作者信息

Ishii H, Kuboki M, Fujii J, Hiraishi S, Kazama M

机构信息

Department of Clinical Biochemistry, Faculty of Pharmaceutical Sciences, Teikyo University, Kanagawa, Japan.

出版信息

Thromb Res. 1990 Mar 15;57(6):847-61. doi: 10.1016/0049-3848(90)90152-3.

DOI:10.1016/0049-3848(90)90152-3
PMID:2382255
Abstract

Participation of thiolprotease in platelet activation was investigated. When platelets were treated with EST (L-trans-epoxysuccinyl-leucylamide (3-methyl)butane-ethyl ester, a membrane-permeable thiolprotease inhibitor) for 30 min, thrombin-induced aggregation and secretion were inhibited, and remained so even when the platelets were washed and resuspended in EST-free medium after the pretreatment. The inhibitory action of EST on thrombin-induced platelet aggregation and secretion was both dose-dependent and incubation-time-dependent. The inhibitory action of EST on platelet aggregation and secretion was shown not only in response to thrombin but also to platelet activating factor (PAF). Pretreatment of platelets with 1 mM EST for 30 min inhibited the 65% of calpain (thiolprotease) activity in platelets. The phosphorylation of 40 kDa and 20 kDa proteins of platelets caused by stimulation with thrombin was blocked by the pretreatment with 1 mM EST. Phosphatidylinositol hydrolysis and inositol-1-phosphate production, which appear after stimulation of platelets with thrombin, were also inhibited by the pretreatment with 1 mM EST. The results suggest that EST was incorporated to inside of platelets, and inhibited activation of platelet through inhibition of thiolprotease.

摘要

研究了硫醇蛋白酶在血小板激活中的作用。当血小板用EST(L-反式环氧琥珀酰-L-亮氨酰胺(3-甲基)丁烷乙酯,一种可透过膜的硫醇蛋白酶抑制剂)处理30分钟时,凝血酶诱导的聚集和分泌受到抑制,并且即使在预处理后将血小板洗涤并重悬于不含EST的培养基中,这种抑制作用仍然存在。EST对凝血酶诱导的血小板聚集和分泌的抑制作用呈剂量依赖性和孵育时间依赖性。EST对血小板聚集和分泌的抑制作用不仅表现在对凝血酶的反应中,也表现在对血小板活化因子(PAF)的反应中。用1 mM EST预处理血小板30分钟可抑制血小板中65%的钙蛋白酶(硫醇蛋白酶)活性。用1 mM EST预处理可阻断凝血酶刺激引起的血小板40 kDa和20 kDa蛋白的磷酸化。凝血酶刺激血小板后出现的磷脂酰肌醇水解和肌醇-1-磷酸生成也受到1 mM EST预处理的抑制。结果表明,EST进入血小板内部,并通过抑制硫醇蛋白酶来抑制血小板的激活。

相似文献

1
Thiolprotease inhibitor, EST, can inhibit thrombin-induced platelet activation.硫醇蛋白酶抑制剂EST可抑制凝血酶诱导的血小板活化。
Thromb Res. 1990 Mar 15;57(6):847-61. doi: 10.1016/0049-3848(90)90152-3.
2
The inhibition of platelet-activating factor-induced platelet activation by oleic acid is associated with a decrease in polyphosphoinositide metabolism.油酸对血小板活化因子诱导的血小板活化的抑制作用与多磷酸肌醇代谢的降低有关。
J Biol Chem. 1990 Oct 25;265(30):18330-8.
3
YD-3, a novel inhibitor of protease-induced platelet activation.YD-3,一种蛋白酶诱导的血小板活化的新型抑制剂。
Br J Pharmacol. 2000 Jul;130(6):1289-96. doi: 10.1038/sj.bjp.0703437.
4
Participation of calpain I activation in the ATP release reaction of platelets stimulated with thrombin.钙蛋白酶I激活参与凝血酶刺激的血小板ATP释放反应。
Biochim Biophys Acta. 1992 Dec 15;1175(1):37-43. doi: 10.1016/0167-4889(92)90007-x.
5
Translocation-independent activation of protein kinase C by platelet-activating factor, thrombin and prostacyclin. Lack of correlation with polyphosphoinositide hydrolysis in rabbit platelets.血小板激活因子、凝血酶和前列环素对蛋白激酶C的非易位依赖性激活。与兔血小板中多磷酸肌醇水解缺乏相关性。
Biochem J. 1990 May 1;267(3):689-96. doi: 10.1042/bj2670689.
6
Stimulation of human platelet Ca(2+)-ATPase and Ca2+ restoration by calpain.钙蛋白酶对人血小板Ca(2+)-ATP酶的刺激作用及Ca2+的恢复
Cell Calcium. 1993 Jun;14(6):455-63. doi: 10.1016/0143-4160(93)90004-p.
7
Thrombin induces serotonin secretion and aggregation independently of inositol phospholipids hydrolysis and protein phosphorylation in human platelets permeabilized with saponin.凝血酶可独立于用皂角苷通透处理的人血小板中的肌醇磷脂水解和蛋白质磷酸化作用,诱导5-羟色胺分泌和聚集。
J Biol Chem. 1985 Jun 10;260(11):7078-83.
8
Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism.抗糖尿病噻唑烷二酮类药物曲格列酮和吡格列酮对人血小板聚集机制的差异作用。
Diabetes. 1998 Sep;47(9):1494-500. doi: 10.2337/diabetes.47.9.1494.
9
Modulation of thrombin-induced platelet aggregation by inhibition of calpain by a synthetic peptide derived from the thiol-protease inhibitory sequence of kininogens and S-(3-nitro-2-pyridinesulfenyl)-cysteine.通过源自激肽原硫醇蛋白酶抑制序列的合成肽和S-(3-硝基-2-吡啶基亚磺酰基)-半胱氨酸抑制钙蛋白酶来调节凝血酶诱导的血小板聚集。
Eur J Biochem. 1993 May 15;214(1):233-41. doi: 10.1111/j.1432-1033.1993.tb17916.x.
10
Carrageenan-induced activation of human platelets is dependent on the phospholipase C pathway.角叉菜胶诱导的人血小板激活依赖于磷脂酶C途径。
Br J Haematol. 1993 Feb;83(2):270-5. doi: 10.1111/j.1365-2141.1993.tb08282.x.

引用本文的文献

1
Role of cysteine proteases and protease inhibitors in gastric mucosal damage induced by ethanol or ammonia in the rat.半胱氨酸蛋白酶和蛋白酶抑制剂在大鼠乙醇或氨诱导的胃黏膜损伤中的作用。
J Clin Invest. 1996 Aug 15;98(4):1047-54. doi: 10.1172/JCI118865.
2
Investigation of the role of calpain as a stimulus-response mediator in human platelets using new synthetic inhibitors.使用新型合成抑制剂研究钙蛋白酶作为人类血小板中刺激-反应介质的作用。
Biochem J. 1991 Mar 1;274 ( Pt 2)(Pt 2):497-502. doi: 10.1042/bj2740497.
3
Activation of calpain I in thrombin-stimulated platelets is regulated by the initial elevation of the cytosolic Ca2+ concentration.
凝血酶刺激的血小板中钙蛋白酶I的激活受胞质Ca2+浓度初始升高的调节。
Biochem J. 1992 Jun 15;284 ( Pt 3)(Pt 3):755-60. doi: 10.1042/bj2840755.